Patient perspectives central for developing new therapies for COPD
The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...
Medscape8 天
Real-Life Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin or ...
About 42% of patients in both groups had had chronic bronchitis for 1-5 years, and about 27% for 5-10 years. The mean number of AECBs in the previous 12 months was 2.7 and 2.6, respectively.
News Medical on MSN7 天
COPD patients' perspectives should guide development of new therapies
The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...
Pharmabiz1 天
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic ...
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...
Medscape5 天
Antibiotic Therapy in Elderly Patients with Acute Exacerbation of Chronic Bronchitis
The relationship between chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) is important, significant and overlapping in nature. This review will analyze the relationship ...
Armed robbery in Revesby7 天
Patient Voices Key in New COPD Therapy Development
The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...
FDA to review GSK’s Nucala for COPD
The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...
GSK says US agrees to look at data for new use of COPD drug
GSK said the US Food and Drug Administration has agreed to look at data from its MATINEE study to support the regulatory review process to obtain a new use of its Nucala drug as an add-on maintenance ...